Head-to-head · computed 2026-08-11
Hims & Hers vs TMates
Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| Hims & Hers | TMates | |
|---|---|---|
| All-in maintenance | $548/mo | $297/mo |
| Best plan rate | $548/mo | $167/mo |
| 12-month total | $6,576 | $2,004 |
| Status | Reported · 2026-08-11 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $297 a month undercuts Hims & Hers's $548 by $251 a month at the 10 mg/wk maintenance basis — $3,012 across a year. TMates's figure is reported (captured 2026-07-14) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's tirzepatide ladder runs $548 a month billed monthly. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats Hims & Hers's $6,576 by $4,572 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Hims & Hers | TMates | |
|---|---|---|
| All-in maintenance | $453/mo | $249/mo |
| Best plan rate | $453/mo | $158/mo |
| 12-month total | $5,436 | $1,896 |
| Status | Reported · 2026-08-11 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $249 a month undercuts Hims & Hers's $453 by $204 a month at the 2.4 mg/wk maintenance basis — $2,448 across a year. TMates's figure is reported (captured 2026-07-14) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's semaglutide ladder runs $453 a month billed monthly. TMates's runs $249 a month billed monthly, and $158 a month on a twelve-month plan. On the twelve-month basis TMates's $1,896 beats Hims & Hers's $5,436 by $3,540 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
TMates carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in.
Structure, side by side
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is Hims & Hers or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Hims & Hers vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Hims & Hers and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $6,576 at Hims & Hers and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Hims & Hers · TMates. Official sites: Hims & Hers ↗ · TMates ↗. Nothing here is medical advice.